Home » Topics » BioWorld Science

BioWorld Science
RSS

University of Nebraska identifies NF-kappaB activation inhibitors

July 16, 2018

OBI Pharma initiates phase I study of OBI-888 in patients with solid tumors

July 16, 2018

Idenix and Merck & Co. disclose anti-HIV-1 compounds

July 16, 2018

Janssen patents OGA inhibitors

July 16, 2018

FDA lifts clinical hold on phase I/II combination study of axalimogene filolisbac plus durvalumab

July 16, 2018

Discovery of [18F]SWR-4-127, a novel PARP-1 selective 18F-PET tracer for neuroimaging

July 16, 2018

Novel zebrafish models of Cantu syndrome using CrispR/Cas9-based nucleotide editing

July 16, 2018

ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine qualifies for phase II/III testing

July 16, 2018

CytoDyn to evaluate PRO-140 in cancer and immunological indications

July 16, 2018

Landos Biopharma initiates phase I study of BT-11

July 16, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...